Meeting
2020 Genitourinary Cancers Symposium
Financial hardship among Medicare beneficiaries prescribed oral targeted therapies for advanced prostate cancer.
Authors
Megan Veresh Caram
University of Michigan Comprehensive Cancer Center, Ann Arbor, MI
Megan Veresh Caram , Mary Oerline , Stacie Dusetzina , Parth K. Modi , Lindsey A. Herrel , Ted A. Skolarus , Brent K. Hollenbeck , Vahakn B. Shahinian
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Prostate Cancer
Track
Prostate Cancer - Advanced,Prostate Cancer - Localized
Sub Track
Quality of Care/Quality Improvement
Citation
J Clin Oncol 38, 2020 (suppl 6; abstr 68)
Abstract #
68
Poster Bd #
C12
Abstract Disclosures
Similar Posters
Poster
2021 Genitourinary Cancers Symposium
Evaluating financial burdens of oral hormonal therapies for patients with prostate cancer.
First Author: Eric B Schwartz
Poster
2020 Genitourinary Cancers Symposium
Overall survival (OS) among Medicare beneficiaries receiving sipuleucel-T (sip-T) versus oral treatment for metastatic castration-resistant prostate cancer (mCRPC).
First Author: Rana R. McKay
Poster
2017 ASCO Quality Care Symposium
Early national dissemination of abiraterone and enzalutamide for advanced prostate cancer in Medicare Part D.
First Author: Megan Veresh Caram
Poster
2024 ASCO Genitourinary Cancers Symposium
The 340B Drug Pricing Program and oral specialty drugs for advanced prostate cancer.
First Author: Kassem S Faraj